Navigation Links
Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
Date:4/22/2010

HARLEYSVILLE, Pa., April 22 /PRNewswire/ -- Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm.  This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS® sugar spheres complements Colorcon's SureSpheres® sugar spheres product line and barrier membrane systems for multiparticulates.  Colorcon will now have two production facilities for sugar spheres offering critical business continuity planning for their customer base.  ETHISPHERES® microcrystalline cellulose pellets, NPTAB® neutral pellets for direct compression, and other excipient products are also added to the Colorcon product portfolio as a result of this acquisition.

The headquarters and main production facilities of NP Pharm, located in Bazainville, France, will become an integral part of the Colorcon network of manufacturing sites.

William Motzer, Colorcon Chief Executive Officer states, "We are excited about this opportunity to expand Colorcon's product offerings and leverage our global distribution, technical service and sales infrastructure."

Newly appointed Chairman and CEO of the Management Board of Ethypharm, Hugues Lecat states, "We are delighted to see NP Pharm join Colorcon, Inc.  The new shareholder will permit NP Pharm to reinforce its development and growth projects.  This divestiture will enable us to go on investing in the growth of Ethypharm, in line with our strategy.  Ethypharm will continue to invest in its R&D sites, notably that of Grand Quevilly, France, our most recent state-of-the-art manufacturing plant, in which we have invested over 15 million Euros over the last two years."

About Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

About Ethypharm

Ethypharm is one of the leading pharmaceutical companies dedicated to the development of innovative medicines.  Its patented technologies offer multiple benefits for patients by improving efficacy, administration, compliance, and reducing side-effects. Ethypharm provides its clients with solutions for the life cycle management of their drugs. The company has one of the broadest portfolios of technologies to become the worldwide privileged partner of pharmaceutical companies. Ethypharm offers customized solutions for the development of the medicines of the future.


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
3. Cambrex Acquires IEP GmbH
4. Essilor Acquires FGX International, Becoming a Major Player in a New Fast-Growing Market
5. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
6. Bioniche Pharma Acquires Seven New Products From GeneraMedix Inc.
7. STD Med Inc. Acquires Facility for Manufacturing and Start-Ups
8. PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group
9. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
10. Advanced Health Media Acquires Advogent
11. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... , Aug. 17, 2017 MJAC2017 , the ... Canna Broadcast Media, today reveals its leading lineup. ... Inc., a global cannabis innovator specializing in the development of ... the conference. MassRoots, Rambridge™ and The Green Organic Dutchman are ... and Namaste Vapes™ as silver sponsors. ...
(Date:8/15/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), is ... residents. Naloxone is available without ... retail pharmacy, G-3320 Beecher Road. ... Drug Administration, is intended to block or reverse the ... loss of consciousness. The medication is often carried by ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
Breaking Medicine Technology:
(Date:8/23/2017)... Jose, California (PRWEB) , ... August 23, 2017 , ... ... San Jose, California, office at 1530 The Alameda, Suite 115. The office is located ... has changed, the contact information remains the same. Clients can still call the office ...
(Date:8/23/2017)... ... August 23, 2017 , ... Loyale Healthcare ... Growth. Mr. Smith joins other recent high-profile hires including Frank Massi, Chief Revenue ... began in 1993, helping physician practices and hospitals automate their clinical and financial ...
(Date:8/23/2017)... ... ... Earlier this month, the Workgroup for Electronic Data Interchange (WEDI) , the ... healthcare information exchange and a trusted advisor to the U.S. Department of Health and ... by Donald W. Rucker, MD, head of the Office of the National Coordinator for ...
(Date:8/23/2017)... ... August 23, 2017 , ... CEFEX, the Centre ... to the standards representing best practices in the retirement plan industry. The independent ... and helps to verify that NFP’s retirement division focuses on putting clients’ interests ...
(Date:8/23/2017)... ... August 23, 2017 , ... Nightingale College continues the ... Back Day is a time Nightingale College dedicates to serving and volunteering for organizations ... on donations and volunteers or those that need a little extra help. , ...
Breaking Medicine News(10 mins):